Rheumatology 2000; 39: 360-368
© 2000 British Society for Rheumatology
Managing seronegative spondarthritides
L. Koehler,
J. G. Kuipers and
H. Zeidler
Division of Rheumatology, Department of Internal Medicine, Medical School Hannover, Carl-Neuberg Strasse 1, D 30625 Hannover, Germany
 |
Introduction
|
|---|
Over the last several decades the classification of rheumatoid
factor-negative arthritis has changed substantially. For some
time it was common practice to consider psoriatic arthritis,
Reiter's syndrome, and ankylosing spondylitis as atypical
or special forms of rheumatoid arthritis, as reflected
in the proposed classification of rheumatic diseases by the
International League Against Rheumatism in 1957 [1]. As described
by Moll
et al. [2] the school of lumpers, who
preferred to group the so-called variants of rheumatoid
arthritis with rheumatoid arthritis itself, were overcome
by the school of splitters, prompted by the idea
that these seronegative arthritides were, in fact, entirely
separate entities. This change was mirrored by the
Nomenclature and Classification of the Rheumatic Diseases proposed by the
American Rheumatism Association in 1963 [1]. Rheumatoid arthritis,
juvenile Still's disease, ankylosing spondylitis, psoriatic
arthritis, and Reiter's syndrome were then classified under
separate headings with
. . . [Full Text of this Article]
 |
How can we overcome the outdated classification of seronegative arthritis by a rational, cost-effective diagnostic strategy?
|
|---|
 |
Which follow-up measurements are really needed for routine management?
|
|---|
 |
Symptom- and problem-orientated therapeutic management
|
|---|
Spinal diseaseEnthesiopathyPeripheral arthritisUnderlying chronic or persistent infectionsManagement of refractory spondarthritides
 |
Future perspectives
|
|---|
 |
Conclusions
|
|---|
 |
Acknowledgments
|
|---|
 |
Notes
|
|---|
 |
References
|
|---|

CiteULike
Connotea
Del.icio.us What's this?